Supplement Label Index / US Pharmaceutical Corporation

Fusion Plus

US Pharmaceutical Corporation · Capsule · On market

Matched compounds

How these doses compare

• Biotin (Vitamin B7): 300 mcg per serving — higher than 55% of 9,338 on-market products declaring it (market median 150 mcg).
• Folate (Vitamin B9): 1,250 mcg DFE per serving — higher than 86% of 5,690 on-market products declaring it (market median 666 mcg DFE).
• Iron: 151.39 elemental mg per serving — among the highest 1% of 7,061 on-market products declaring it (market median 5 elemental mg).
• Niacin (Vitamin B3): 10 mg NE per serving — higher than 16% of 11,982 on-market products declaring it (market median 20 mg NE).
• Pantothenic Acid (Vitamin B5): 6 mg per serving — higher than 24% of 9,834 on-market products declaring it (market median 14 mg).
• Riboflavin (Vitamin B2): 3 mg per serving — higher than 42% of 9,701 on-market products declaring it (market median 4 mg).
• Thiamine (Vitamin B1): 2 mg per serving — higher than 35% of 9,706 on-market products declaring it (market median 5 mg).
• Vitamin B12 (Cobalamin): 12 mcg per serving — higher than 32% of 14,041 on-market products declaring it (market median 35 mcg).
• Vitamin B6 (Pyridoxine): 10 mg per serving — higher than 53% of 15,068 on-market products declaring it (market median 6 mg).
• Vitamin C: 75 mg per serving — higher than 35% of 18,522 on-market products declaring it (market median 120 mg).

Per serving as declared; serving sizes and daily directions differ between products.

Excipients

• Hypromellose
• Magnesium Stearate — Food Additive Index
• Microcrystalline Cellulose
• Titanium Dioxide — Food Additive Index

Label statements

• other: Indications: Fusion Plus is indicated for the treatment of iron deficiency anemia and folate deficiency as in extended convalescence, menorrhagia, pregnancy, puberty, excessive blood loss and advanced age. Also for treatment of condition in which iron deficiency and vitamin C deficiency occur together along with a deficient intake or increased need for B-complex vitamins in chronic and acute illness as well as cases of metabolic stress and convalescence.
• warning: Contradictions: Fusion Plus is contraindicated in patients with a known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. It is also contradicated in patients suffering from pernicious anemia as folic acid may obscure its signs and symptoms.
• other: Ferrous Fumarate and Polysaccharide Iron Complex: All Fusion Plus products include a unique patented source of iron, e.g. Ferrous Fumarate and Polysaccharide Iron Complex (U.S. Patent No. 11/243,043 Pending).
• claim: “An increase in tolerability is observed with the (patended formulation) and is believed to occur as the result of distributing the total iron content in the composition among compounds that provide iron to the patient’s blood stream via two different mechanisms. The ferrous salts are readily absorbed in the upper gut, by direct dissolution and absorption of the ferrous iron by the bloodstream. However, the iron available from PIC is absorbed in the lower gut, via an active protein transport mechanism”.
• claim: Clinical Studies: Picinni, L.-Ricciotti, M. 1982. Therapeutic effectiveness of an iron-polysaccharide complex in comparison with iron fumarate in the treatment of iron deficiency anemias: Panminerva Medica-Europa Medica, Vol. 24, No.3. pp.213-220 (July-September 1982).
• claim: Folic Acid: Folic acid is one of the important hematopoietic agents necessary for proper regeneration of the blood-forming elements and their function. Additionally, folic acid increases jejunal glycolytic enzymes and is involved in the desaturation and hydroxylation of long-chain fatty acids in the brain. A deficiency in folic acid results in megaloblastic anemia.
• warning: Warning: Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
• warning: Precaution: Folic acid in doses above 0.1 mg – 0.4 mg daily may obscure pernicious anemia, in that hematological remission can occur while neurological manifestations remain progressive.
• warning: The use of this product by immunocompromised patients or treatment of any disorder must be medically supervised by a physician.
• other: Dosage And Administration: Adults (persons over 12 years of age), one (1) capsule daily, between meals, or as prescribed by a physician.
• warning: Do not exceed recommended dosage.
• warning: Do not administer to children under the age of 12.
• other: How Supplied: Fusion Plus are Pearl Red opaque Vcaps capsules imprinted “US” logo and “F Plus” in white. Child resistant bottles of 30 capsules, NDC# 52747-502-30. Dispense in a tight, light-resistant container as defined in the USP/NF with a child resistant closure.
• other: Store at controlled room temperature 15(0) to 30(0)C (59(0) to 86(0)F). Keep in a cool, dry place.
• warning: Caution: RX only
• other: Vcaps and the Vcaps logo are trademarks used under license.
• claim: N
• identity: Iron / Folic Acid/ Vitamin / Probiotic Supplement Capsules
• claim: Consult package literature for full prescription information. You should contact your healthcare provider for medical advice about adverse events.
• other: Manufactured with Vcaps plus capsule shells.
• claim: Manufactured in a FDA registered facility in the USA.
• warning: Warning: Accidental overdose of iron-containing products is a leading cause of fatal poisoning inchildren under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or poison control center immediately.
• claim: Lift here for full prescription information
• other: Rev. 04/2013

View original label on DSLD → · Add to the Stack Checker